| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Dec 12, 2025 | IRADIMED CORP | CFO | Sell | 17.5 | -15,714 | -39.85% | ✗ | $1.5M |
| Dec 7, 2025 | Dec 10, 2025 | IRADIMED CORP | CFO | Sell | 17.5 | -11,650 | -26.70% | ✗ | $1.1M |
| Nov 10, 2025 | Nov 12, 2025 | IRADIMED CORP | CFO | Sell | 20.0 | -10,651 | -80.99% | ✗ | $900.2K |
| Jun 20, 2025 | Jun 23, 2025 | IRADIMED CORP | CFO | Sell | 22.5 | -1,412 | -9.70% | ✗ | $82.2K |
| Jun 20, 2024 | Apr 4, 2025 | IRADIMED CORP | CFO | Sell | 22.5 | -1,412 | -13.87% | ✗ | $60.1K |
| Dec 2, 2024 | Dec 2, 2024 | IRADIMED CORP | CFO | Sell | 22.5 | -2,500 | -36.32% | ✗ | $135.4K |
| Jun 20, 2023 | Jun 22, 2023 | IRADIMED CORP | CFO | Sell | 22.5 | -1,412 | -17.02% | ✗ | $67.6K |
| Mar 22, 2022 | Mar 28, 2022 | EKSO BIONICS HOLDINGS, INC. | CFO | Sell | 47.5 | -3,462 | -8.97% | ✗ | $9.8K |
| May 31, 2019 | Jun 19, 2019 | EKSO BIONICS HOLDINGS, INC. | CFO | Sell | 26.3 | -10,292 | -68.61% | ✗ | $14.1K |